ARCHIVES

FDA News: Agency Abandons Plan To Merge Two Offices, Citing Delay Request From Employees’ Union

This article is from The Cancer Letter archive.

Vol. 24 No. 24 | June 19, 1998

Download PDF Visit The Full Archive

Related Articles

New Creatinine Test Raises Questions About Accuracy Of Carboplatin Dosing

October 8, 2010

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

April 26, 1996

Breast Cancer Survivors Report More Severe Fatigue Than Healthy Women

September 28, 2007

In Brief: Shingleton To Head AACI; Saunders To Get Two More Jobs At U. Texas Medical Branch

January 21, 1977

Clinical Trials: For ER+ Breast Cancer, Post-Tamoxifen, NSABP Testing Aromasin In Large Trial

June 1, 2001

NCI Official Says He Hopes to “Put More Money” Into SPOREs.

April 14, 2006